Kronox Lab Sciences IPO | The IPO comprises solely an offer-for-sale of 95.7 lakh equity shares with no fresh issue component. Therefore, the entire issue proceeds will go to the selling shareholders.
Kronox has a high purity speciality fine chemicals portfolio with more than 185 products. It has served over 625 customers in the last five financial years.